BackOpthea Limited Overview
Opthea Limited - ADR

Opthea Limited Return on Equity

Valuation check: OPT's ROE is 236.09%, above the Healthcare sector average of 13.26%.

Get informed when a big investor buys or sells

+ Follow

ROE

236.09%

Return on Equity

236.09%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

Opthea Limited (OPT) FAQ

Opthea Limited (OPT) currently reports a ROE of 236.09%. That is above the Healthcare sector average of 13.26%. Use the charts on this page to explore Opthea Limited's ROE history and peer comparisons.

Opthea Limited's ROE of 236.09% is higher than the Healthcare sector average of 13.26%. That is roughly 1680.0% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' ROE, but Opthea Limited's current 236.09% should be judged against Healthcare norms (sector average: 13.26%) and against OPT's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current ROE of 236.09%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 13.26%. From there, open related valuation or income-statement pages for Opthea Limited, and consider following OPT for alerts when major investors trade the stock.

Opthea Limited is classified in the Healthcare sector. On ROE, it currently shows 236.09% versus a sector average near 13.26%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing OPT with unrelated industries.